Heritage Playbook Sets Up Antitrust Pressure on Proxy Advisers
Republicans and companies have looked to securities regulators to curb firms that advise shareholders on environmental, ...
The Manila Times18h
Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®
"The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...
Alvotech S.A.: Alvotech and Dr. Reddy's Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia and Xgeva
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...
DatacenterDynamics23h
Data and sustainability: An award-winning act
From assessment and certification to operational efficiency, GBI plays the lead role in driving sustainability through ...
Environmental Finance14h
Making a market in sustainable finance
Baylie Thompson: Brazil's seven-year, $2 billion sustainability bond issued in June 2024 was more than two times ...
White misled board; Trump’s terrifying deal; Last night’s market shock
Sorry, there has been an error loading this content. Please try again later.
Financial Services Roundup: Market Talk
The latest Market Talks covering Financial Services. Exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1151 ET – Investors increasingly expect European small caps to perform better ...